Lung Cancer Clinical Trials

Clinical Trial: Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer

Clinical Trial: Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours

Clinical Trial: Lung Cancer Location: a Repository

Clinical Trial: Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection

Clinical Trial: Biomarker Discovery and Validation in Lung Cancer

Clinical Trial: DNA Analysis in Predicting Lung Cancer Risk

Clinical Trial: Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

Clinical Trial: Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

Clinical Trial: Surgical Versus Non-surgical Staging of Lung Cancer

Clinical Trial: Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Clinical Trial: Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Clinical Trials: Phase I-II Study of Dasatinib and Erlotinib in Non-Small Cell Lung Cancer

Clinical Trials: A Phase II Study of TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer

Amgen Protocol 20060534 - A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer

For a complete listing of clinical trials pertaining to Lung Cancer via ClinicalTrials.gov, click here.

Lung Cancer News

New PCR-Based Assay Better Predicts Lung Cancer Survival

Bevacizumab delays return of ovarian cancer

ACS annual report says cancer mortality is decreasing

Cancer-Related Mortality Continues to Decrease

High EGFR plus cetuximab extends survival in lung cancer

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Cancer care is expensive.
CancerCare can help.


Connect Booklets
FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions